Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 11Recruiting 4Terminated 3Not yet recruiting 3Active not recruiting 3Unknown 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Colorectal Neoplasms 4Urinary Bladder Neoplasms 3Non-Muscle Invasive Bladder Neoplasms 3Appendiceal Neoplasms 2Urothelial Carcinoma Ureter 1Peritoneal Neoplasms 1Peritoneal Diseases 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Carcinoma, Transitional Cell 1Carcinoma in Situ 1

Interventions

Gemcitabine 6Radiotherapy 4Mitomycin 3Epirubicin 2toripalimab 1tislelizumab 1pirarubicin 1hydroxycamptothecinum 1Watchful Waiting 1Maintenance 1Injections 1Docetaxel 1BCG Vaccine 1Anesthesia, Spinal 1Anesthesia, General 1ALT-803 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Non-Muscle Invasive Bladder Neoplasms × Mitomycin × Clear all
NCT07424287 2026-06-02

A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Phase 3 Not yet recruiting
236 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT07189793 2025-09-24

OHAI-NMIBC-01

First Affiliated Hospital of Wenzhou Medical University

Phase 2 Not yet recruiting
106 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell

NCT06227065 2024-01-26

POLO

University of Bern

Phase 2 Not yet recruiting
28 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡